Surrogate-based tumor motion estimation and tracing methods are commonly used in radiotherapy despite the lack of continuous real time 3D tumor and surrogate data. In this study, we propose a method to simultaneously track the tumor and external surrogates with dynamic MRI, which allows us to evaluate their reproducible correlation. Four MRIcompatible fiducials are placed on the patient's chest and upper abdomen, and multi-slice 2D cine MRIs are acquired to capture the lung and whole tumor, followed by two-slice 2D cine MRIs to simultaneously track the tumor and fiducials, all in sagittal orientation. A phase-binned 4D-MRI is first reconstructed from multi-slice MR images using body area as a respiratory surrogate and group-wise registration. The 4D-MRI provides 3D template volumes for different breathing phases. 3D tumor position is calculated by 3D-2D template matching in which 3D tumor templates in 4D-MRI reconstruction and the 2D cine MRIs from the two-slice tracking dataset are registered. 3D trajectories of the external surrogates are derived via matching a 3D geometrical model to the fiducial segmentations on the 2D cine MRIs. We tested our method on five lung cancer patients. Internal target volume from 4D-CT showed average sensitivity of 86.5% compared to the actual tumor motion for 5 min. 3D tumor motion correlated with the external surrogate signal, but showed a noticeable phase mismatch. The 3D tumor trajectory showed significant cycle-to-cycle variation, while the external surrogate was not sensitive enough to capture such variations. Additionally, there was significant phase mismatch between surrogate signals obtained from fiducials at different locations.
INTRODUCTION
Respiration-induced tumor motion is a major obstacle for achieving high-precision radiotherapy of cancers in the thorax and abdomen. Common motion management strategies currently used in radiotherapy include respiration gating, real-time tumor tracking, and breath-hold techniques where external or internal surrogates are typically used to derive the patient and tumor position [1] [2] [3] [4] . While these methods may yield an improved treatment with reduced margins, they have inherent limitations. Tracking techniques often expose patients to ionizing radiation. Additionally, an invasive procedure may be necessary for internal surrogate marker placement. Anatomic motion due to breathing is significantly variable between breathing cycles, treatment fractions, individual patients, tumor location, and sometimes shows complex patterns [5] [6] . Tumor motion management strategies are recommended for quality care by national treatment guidelines in radiation oncology [7] . However, an understanding of the uncertainty behind surrogate-based motion management strategies is limited.
Computed tomography (CT) is the reference imaging modality for radiotherapy planning and dose computation. Accordingly, respiration-correlated CT or 4D-CT is considered an effective tool to characterize tumor and normal tissue motion during radiotherapy. 4D-CT has become the gold standard for radiotherapy treatment planning in the context of breathing motion, and a pre-treatment 4D-CT scan is typically obtained to derive internal target motion for radiotherapy planning. However, it is often overlooked that 4D-CT is a snapshot representation of a single-breathing cycle. 
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The lin t ≤1 , l 2 , l 3 , l 4 ) . Because the fiducial is shown as bright circles in MR images as shown in Figure 2 (c), they are segmented by thresholding and morphological filtering and indexed by their locations automatically. The fiducial tracking problem becomes a rigid registration problem and can be solved by fitting the fiducial model F to their segmentations in the MR images. The image plane is defined as • 0, where o is the offset and n is the normal vector. The intersection point x between the line segment and the plane can be computed by
where /|| ||. Let : → be the rigid transformation of the line segment to the image plane. To estimate the 3D center of the fiducial markers from the 2D MR images, we find the optimal transformation which minimizes the cost function defined as
where is the center of the segmented marker in 2D MRI as shown in Figure 2 (c) and
The rigid transformation T is a parametric function of xyz-translation and Euler angles in our model, and (2) becomes a non-linear least squares problem of the parameters. To find an optimal solution, we use the well-known LevenbergMarquardt algorithm, and the initial solution is estimated from the trapezoidal geometry of the fiducial image in the 2D MR images. Finally, the fiducial centroid trajectory of each fiducial is computed based on the estimated transformation, yielding a surrogate signal.
RESULTS
We tested our method on five lung cancer patients. All MR images are acquired using Siemens Magnetom Espree 1.5T scanner (Siemens Medical Solutions, Malvern, PA) with a balanced steady-state free precession sequence (TrueFISP, TR≈3 ms, TE=1.22 ms, flip angle=77-79°). Acquired images were corrected for geometric distortion using the Siemens distortion correction algorithm implemented in the Syngo platform (Siemens AG, Erlangen, Germany). The obtained 2D MR images have a spatial resolution of 2×2 mm 2 with slice thickness and spacing of 5 mm. The slice acquisition frequency was approximately 4 Hz on average. The number of slices in multi-slice MR scan varied between 15 and 20 depending on the tumor size. Total scan times were 10 minutes for multi-slice MRI and 5 minutes for twoslice MRI. Figure 3 shows two examples of the tumor and surrogate signal comparison. In all five lung cancer cases, the tumor motion was correlated with the surrogate signal estimated from fiducials in general as shown in Figure 3(a) , but often showed significant phase mismatch as shown in Figure 3(b) . The phase mismatch was not systematic, but transient, which may pose significant problem in external surrogate-based tumor motion tracking during radiotherapy. Additionally, there were significant tumor trajectory variations depending on the patient's breathing pattern that were not properly captured by the surrogate signals. We also observed that there was significant phase difference between the upper and lower fiducials. This is due to the variation of the surface motion around the upper and lower (close to abdomen) chest areas depending on breathing patterns. This implies that the position of the external fiducial should be chosen with caution. Also, tumor locations cause different patterns of mismatches between the tumor motion and the surrogate signals. Therefore, tumor locations also have to be considered with care when estimating their motion based on surrogate signals.
The overall phase difference between the tumor and fiducial motions are shown in Table 1 . Since lateral motion was very small for these cases, we only show superior-inferior (SI) and anterior-posterior (AP) directional motions in accurate way to manage the tumor motion during radiotherapy. These data suggests that a surrogate-based tumor motion management strategy during radiation therapy should be used with caution. More extensive evaluation on a larger patient cohort is underway.
